RA Capital Management - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 148 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
RA Capital Management ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$19,387,306
-58.8%
1,131,775
-53.0%
0.44%
-54.0%
Q4 2022$47,107,906
+40.1%
2,407,149
+14.2%
0.96%
+33.2%
Q3 2022$33,630,000
+16.0%
2,107,1490.0%0.72%
-7.2%
Q2 2022$28,994,000
-13.2%
2,107,1490.0%0.77%
+6.0%
Q1 2022$33,419,000
-27.3%
2,107,1490.0%0.73%
-10.1%
Q4 2021$45,999,000
-27.0%
2,107,1490.0%0.81%
-7.1%
Q3 2021$62,983,000
-32.5%
2,107,1490.0%0.87%
-41.7%
Q2 2021$93,326,000
-0.2%
2,107,1490.0%1.50%
+6.2%
Q1 2021$93,494,000
-20.2%
2,107,149
-1.4%
1.41%
-13.9%
Q4 2020$117,143,0002,136,0811.64%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders